Inhibition of the NLRP3 inflammasome with MCC950 partially reversed the liver inflammation and liver scarring, particularly in obese diabetic mice that mimics NASH in humans (Mridha et al., 2017). The gene discussed is NLRP3; the disease is metabolic dysfunction-associated steatohepatitis.